Busan, South Korea

Chang Hun Joo

This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chang Hun Joo. Retrieved from https://idiyas.com/inventor/chang-hun-joo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chang Hun Joo - Innovator in Diagnostic Compositions

Introduction

Chang Hun Joo, based in Pusan, South Korea, is a notable inventor who has made significant contributions to the field of diagnostics through his innovative research and development. With a sole patent to his name, he continues to pave the way for advanced detection methods in health sciences.

Latest Patents

Chang Hun Joo holds a patent for a "Composition for detecting β-1,3-glucan." This invention pertains to a novel composition that allows for the detection of minimal quantities of β-1,3-glucan. The composition showcases phenoloxidase activity in the presence of calcium ions. The method involves collecting a sample from a specimen, adding his composition along with calcium ions, and subsequently measuring the phenoloxidase activity to detect β-1,3-glucan.

Career Highlights

Joo's career includes his role at Samyang Genex Corporation, where he applies his expertise in developing diagnostic solutions. His work emphasizes innovation in biological detection methods, contributing to advancements in medical diagnostics.

Collaborations

Throughout his career, Chang Hun Joo has collaborated with esteemed colleagues such as Joong Hyuck Auh and Bu Soo Park. Their collective efforts have further enhanced the research and development capabilities within their field.

Conclusion

Chang Hun Joo’s innovative spirit exemplifies the qualities of a dedicated inventor. His contributions, particularly through his patent for the detection of β-1,3-glucan, underscore his commitment to advancing diagnostic technologies. As he continues his work at Samyang Genex Corporation, his impact on the industry and the medical field remains significant, making him a valuable asset to the innovation landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…